
Tobias Berg, MD
Leukemia Specialist
Hamilton, ON - Canada
Clinical expertise
Spoken languages
About
The focus of my research is on understanding determinants of treatment response in Acute Myeloid Leukemia (AML) and on developing novel treatment approaches based on this understanding. While modern treatment approaches including allogeneic stem cell transplantation can often result in a remission in patients with AML, many patients still experience relapse making AML a highly difficult to treat and resistant cancer. The development of leukemia as well as relapse (in particular after allogeneic stem cell transplantation) are often driven by epigenetic processes. We therefore study the role of epigenetic regulators in AML and their interplay with regulators of lineage-specific differentiation, metabolism, and immune recognition. In these studies, we now use functional model systems in vitro and in vivo, single-cell sequencing analysis as well as functional metabolic studies. To facilitate this research, we are collecting primary samples from patients with hematological malignancies in our HHS McMaster Cancer Research Stem Cell Bank.
Care center